Our Clients
Atlantic-Pacific successfully raised capital across a wide array of private capital strategies and structures - commingled blind pools, JVs, continuation vehicles and SPVs.
Evolution Credit Opportunities
Fund II
$1,000,000,000
March 2023
Gallatin Point Capital Partners
Fund II
$1,570,000,000
December 2022
Project Zenith
$480,000,000
December 2022
Project Color
Amount Not Disclosed
October 2022
Panacea Venture Healthcare Fund II
$276,000,000
July 2022
GSV Ventures
Fund III
$285,000,000
July 2022
Openspace Ventures Plus
$200,000,000
March 2022
Project Epitome
Amount Not Disclosed
March 2022
Project Superior
Amount Not Disclosed
March 2022
Project Accel
$100,000,000
March 2022
Project Pristine
$400,000,000
February 2022
Project Secure
$179,000,000
February 2022
Project Onderdonk/Stickney
Amount Not Disclosed
February 2022
Melody Communications Infrastructure II
$1,950,000,000
December 2021
Merit Fund VII
$550,000,000
December 2021
BC Partners Credit SOF II
$1,200,000,000
December 2021
Newbury Equity
Partners V
$2,000,000,000
November 2021
Lightyear Capital V
$1,600,000,000
October 2021
Tilia Fund II
$200,000,000
October 2021
Confidential
$4,500,000,000
August 2021
Growth Fund III
$335,000,000
July 2021
Opportunity Fund II
$130,000,000
July 2021
Project Bucks-Gamma
$80,000,000
June 2021
Mountaingate Capital Fund II
$476,000,000
May 2021
Project Smile
$240,000,000
April 2021
Industry Ventures Secondary IX
$850,000,000
March 2021
Openspace Ventures III
$200,000,000
March 2021
Project Silk Road
$225,000,000
February 2021
AVAIO Digital Partners
$375,000,000
February 2021
Southfield Capital
Fund III
$303,000,000
January 2021
IMM RoseGold IV
$1,800,000,000
December 2020
Falcon Private Credit Opp. Fund VI
$1,300,000,000
December 2020
Project T-Cell
$130,000,000
December 2020
CapMan Nordic Infrastructure I
$190,200,000
October 2020
OSP Value Fund III & III-B
$550,000,000
October 2020
Project Telecom
Amount Not Disclosed
October 2020
Legend Capital Fund VIII
$500,000,000
September 2020
Castleforge Partners Fund III
£270,338,000
July 2020
Project Ambrosia
$70,000,000
July 2020
Project Goliath
$620,000,000
June 2020
Ara Fund I
$396,030,000
April 2020
Arbour Lane
Credit Opportunity II
$1,225,000,000
March 2020
Reverence Capital Partners Fund II
$1,200,000,000
January 2020
Peerbridge Health
$10,000,000
December 2019
Revelstoke Capital Partners
$660,000,000
December 2019
Union Acquisition Corp. II
$200,000,000
October 2019
Bioceres Crop Solutions
$20,000,000
October 2019
Vertex China IV
$275,000,000
September 2019
Kinea Private Equity Fund IV
R$1,549,000,000
July 2019
NovaQuest Pharma Opp.
Fund V
$1,159,684,543
June 2019
Panacea Venture Healthcare Fund
$180,000,000
December 2018
Longpoint Realty Fund I
$280,376,000
October 2018
Red Dog Equity
$70,000,000
October 2018
Dalmore Capital 3 LP
£950,000,000
August 2018
InfraRed Active Real Estate Fund IV
£521,625,000
July 2018
Waterous Energy Fund I
C$1,362,000,000
June 2018
Spanish Gas
Distribution Network
€55,007,039
May 2018
Starcrest China Real Estate
Fund II
$276,500,000
February 2018
Union Acquisition Corp.
$115,000,000
February 2018
Activum SG Fund V
€489,201,000
December 2017
Emergent Cold
$1,000,000,000
December 2017
Forebright Capital
$58,200,000
October 2017
Growth Capital Partners
Fund IV
£205,000,000
June 2017
Legend Capital Fund VII
$448,000,000
March 2017
CIVC Partners Fund V
$398,293,000
March 2017
Falcon Strategic Partners V
$1,006,465,250
March 2017
Surterra Holdings
$15,000,000
August 2016
Mercer Real Estate Partners II
£235,300,000
July 2016
Waterton Mining Parallel Fund
$725,000,000
June 2016
BCP Energy Services Fund
$750,000,000
March 2016
Ampersand Fund 8
$267,000,000
January 2016
Peerbridge Health
$12,300,000
January 2016
NovaQuest Pharma Opportunities IV
$990,000,000
December 2015
Catalyst Fund Ltd. Partners V
$1,530,868,000
September 2015
True North Real Estate Fund III
$547,666,492
July 2015
Arc Energy Fund 8
C$1,555,500,000
June 2015
Mesoamerica Pledge Fund
$200,000,000
June 2015
Tremendous Asia Partners
$15,000,000
March 2015
InfraRed Active Real Estate Fund III
£475,000,000
November 2014
Infracapital Partners II
£1,000,000,000
October 2014
Clairvest Capital Fund V
$600,000,000
September 2014
Activum SG Fund III
€380,000,000
April 2014
Alterna CCA Fund II
$772,000,000
March 2014
Waterton Precious Metals
Fund II
$1,000,000,000
March 2014
Falcon Strategic Partners IV
$909,667,501
January 2014
Parallax Capital Partners
$115,500,000
January 2014
Catalyst Capital Limited Partnership IV / PP
$1,009,772,000
October 2013
Drug Royalty III
$1,450,000,000
August 2013
Clearview Capital Fund III
$325,000,000
June 2013
DIF Infrastructure III
€800,000,000
February 2013
